Abstract
Background
Para-aortic nodal dissection in patients with biliary carcinoma has not been performed routinely worldwide. Therefore, the prognostic impact of para-aortic lymph node metastasis in biliary carcinoma has not yet been evaluated. The aim of this study was to clarify the prognostic impact of para-aortic lymph node metastasis in biliary carcinoma.
Methods
Of 113 patients with biliary adenocarcinoma who underwent surgical resection with regional and para-aortic lymph node dissection, para-aortic lymph node metastasis was found in 17 patients (15%) by final pathological examination. Relationships between clinicopathological factors, including para-aortic lymph node metastasis, and survival were analyzed by univariate and multivariate analyses.
Results
Overall survival rates for the 113 patients were 82% at 1 year, 65% at 2 years, 58% at 3 years, and 52% at 5 years. Univariate analysis revealed that better tumor differentiation (P = 0.044), negative lymph node metastasis (P < 0.001), negative para-aortic lymph node metastasis (P = 0.007), negative surgical margin status (P < 0.001), lower UICC pT factor (P = 0.009), and earlier UICC stage (P < 0.001) were associated significantly with longer survival. Lymph node metastasis (P = 0.004) but not para-aortic lymph node metastasis (P = 0.323) remained associated independently with longer survival by multivariate analysis. Five-year survival rates for node-negative patients, node-positive patients without para-aortic lymph node metastasis, and node-positive patients with para-aortic lymph node metastasis were 72, 31, and 24%, respectively.
Conclusion
Radical resection should not be abandoned for patients with para-aortic lymph node metastasis in biliary adenocarcinoma.
Similar content being viewed by others
References
Rea DJ, Munoz-Juarez M, Farnell MB et al (2004) Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139:514–523 discussion 523-525
Unno M, Katayose Y, Rikiyama T et al (2010) Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 17:463–469
Murakami Y, Uemura K, Hayashidani Y et al (2007) Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg 31:337–342 discussion 343-344
Woo SM, Ryu JK, Lee SH et al (2007) Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 14:3195–3201
Yoshida T, Matsumoto T, Sasaki A et al (2002) Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 137:69–73
Hasegawa S, Ikai I, Fujii H et al (2007) Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 31:1256–1263
Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588
Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727
Uenishi T, Kubo S, Yamazaki O et al (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422
Guglielmi A, Ruzzenente A, Campagnaro T et al (2009) Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33:1247–1254
Sasaki R, Itabashi H, Fujita T et al (2006) Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer–from the perspective of mode of lymph node involvement and surgical outcome. World J Surg 30:36–42
Shimizu H, Kimura F, Yoshidome H et al (2007) Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepatobiliary Pancreat Surg 14:358–365
Kim RD, Kundhal PS, McGilvray ID et al (2006) Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 202:112–119
Duffy JP, Hines OJ, Liu JH et al (2003) Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. Arch Surg 138:941–950
Kurosaki I, Tsukada K, Hatakeyama K et al (1996) The mode of lymphatic spread in carcinoma of the bile duct. Am J Surg 172:239–243
Kayahara M, Nagakawa T, Ohta T et al (1997) Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 121:611–617
Tsukada K, Kurosaki I, Uchida K et al (1997) Lymph node spread from carcinoma of the gallbladder. Cancer 80:661–667
Tsuji T, Hiraoka T, Kanemitsu K et al (2001) Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 129:401–407
Kondo S, Nimura Y, Hayakawa N et al (2000) Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 87:418–422
Kitagawa Y, Nagino M, Kamiya J et al (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para aortic node dissection. Ann Surg 233:385–392
Moriya T, Kimura W, Hirai I et al (2006) Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 13:549–555
Sakata J, Shirai Y, Wakai T et al (2007) Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. Eur J Surg Oncol 33:346–351
Yonemori A, Kondo S, Matsuno Y et al (2009) Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer. Br J Surg 96:509–516
Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2010) Internatinal Union Against Cancer (UICC): TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, New York
Murakami Y, Uemura K, Sudo T et al (2009) Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 13:1470–1479
Murakami Y, Uemura K, Sudo T et al (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250:950–956
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Shinkai H, Kimura W, Sata N et al (1996) A case of gallbladder cancer with para-aortic lymph node metastasis who has survived more than seven years after the primary extended radical operation. Hepatogastroenterology 43:1370–1376
Murakami Y, Yokoyama T, Takesue Y et al (2000) Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. Surgery 127:105–106
Penz M, Kornek GV, Raderer M et al (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12:183–186
André T, Tournigand C, Rosmorduc O et al (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15:1339–1343
Patt YZ, Hassan MM, Aguayo A et al (2004) Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 101:578–586
Ueno H, Okusaka T, Ikeda M et al (2004) Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 91:1769–1774
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murakami, Y., Uemura, K., Sudo, T. et al. Is Para-aortic Lymph Node Metastasis a Contraindication for Radical Resection in Biliary Carcinoma?. World J Surg 35, 1085–1093 (2011). https://doi.org/10.1007/s00268-011-1036-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-011-1036-4